Committed to growth and innovation
Vytrus Biotech is a biotechnology company that develops cosmetic active ingredients from plant stem cell technology at industrial scale.
Share information
This section will provide the reader with further details in the coming weeks.
ACCESS TO BME Growth WEBSITE
Financial data
Find and download Vytrus Biotech financial information
Key documents
Press room
Read latest news about Vytrus Biotech:
26/01/2023
Vytrus Biotech receives valuation of 26.4 million euros according to GVC Gaesco
The biotechnology company has received a valuation report from GVC Gaesco Valores, which estimates a target price of 3.71€/share December 2023e for the company, equivalent to 26.4 million euros, 10% more than yesterday's closing price.
03/01/2023
Vytrus registers its first patent in Europe, USA and Japan for hair loss
Europe, USA and Japan have granted the Spanish stock market-listed company with a patent in the field of hair loss prevention and treatment, framed within the proprietary firm’s biotechnology platform called Phyto-Peptidic Fractions. Through this platform, Vytrus has developed several active ingredients from plant stem cells for applications in skincare and haircare.